Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label Study Comparing the Effects of Low-dose Cyclosporine vs Cyclosporine Withdrawal on Renal Function in Kidney Transplant Patients Treated With CellCept and Daclizumab
This study will compare kidney function in kidney transplant patients following treatment with various combinations of Zenapax, CellCept, corticosteroids, and Neoral (Cyclosporine). The anticipated time on study treatment is 6-12 months, and the target sample size is 500+ individuals.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Birmingham, Alabama, United States
San Francisco, California, United States
Gainesville, Florida, United States
Atlanta, Georgia, United States
Livingston, New Jersey, United States
Philadelphia, Pennsylvania, United States
Charleston, South Carolina, United States
Falls Church, Virginia, United States
Adelaide, Australia
Sydney, Australia
Start Date
December 1, 2000
Primary Completion Date
March 1, 2006
Completion Date
March 1, 2006
Last Updated
November 2, 2016
539
ACTUAL participants
Corticosteroids
DRUG
Neoral
DRUG
Neoral
DRUG
Zenapax
DRUG
mycophenolate mofetil [CellCept]
DRUG
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07294547